Appointments: Adherium, Pharmalink, Cleave Biosciences, Decibel, Minoryx, Oxular and Aelix
This week's roundup includes board appointments by Pharmalink, Oxular, Decibel Therapeutics and executive appointments by various companies including e-Therapeutics, where Amgen's current executive director of corporate development has been appointed CEO, Cleave Biosciences and IXICO.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.